Clinical efficacy of atezolizumab plus bevacizumab and chemotherapy in KRAS-mutated non-small cell lung cancer with STK11, KEAP1, or TP53 comutations: subgroup results from the phase III IMpower150 trial
===========================================================================================================================================================================================================

* Howard Jack West
* Mark McCleland
* Federico Cappuzzo
* Martin Reck
* Tony SK Mok
* Robert M Jotte
* Makoto Nishio
* Eugene Kim
* Stefanie Morris
* Wei Zou
* David Shames
* Meghna Das Thakur
* Geetha Shankar
* Mark A Socinski